Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Connected Drug Delivery Devices Market Set To Climb From $11.48 Billion In 2026 To $27.01 Billion By 2030
The market size for connected drug delivery devices has expanded exponentially in recent years. It is forecast to increase from $9.27 billion in 2025 to $11.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.8%. This historical growth is linked to the growing adoption of chronic disease management devices, an increasing prevalence of diabetes and respiratory disorders, technological advancements in smart syringes and inhalers, rising healthcare digitization initiatives, and increasing awareness about medication adherence.
The connected drug delivery devices market is projected to experience substantial growth in the upcoming years. It is anticipated to reach $27.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.9%. This expansion during the forecast period is driven by factors such as increasing demand for remote patient monitoring, the development of connected healthcare ecosystems, the incorporation of AI-based predictive analytics, the rise of wearable drug delivery devices, and supportive government policies for digital health adoption. Key trends identified for this period encompass personalized medication adherence monitoring, remote patient monitoring solutions, integration with electronic health records (EHR), data-driven dose optimization, and the provision of real-time alerts and notifications.
Get A Free Sample Report With In-Depth Market Insights:
Connected Drug Delivery Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The escalating significance of remote patient monitoring is projected to stimulate expansion within the connected drug delivery device market moving ahead. This method of healthcare delivery utilizes technology to remotely monitor patient health and medical information. Connected drug delivery devices augment RPM by allowing precise tracking of drug consumption and compliance, thereby facilitating prompt medical responses and offering customized care strategies. As an illustration, the Journal of Medical Internet Research, a peer-reviewed publication based in Canada, stated in May 2024 that 38.78% of adults in the US had utilized telehealth services over the preceding year. Consequently, the heightened emphasis on remote patient monitoring is fueling the expansion of the connected drug delivery device market.
Connected Drug Delivery Devices Market Segment Analysis Spotlighting Growth Areas
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
Connected Drug Delivery Devices Market Innovation Trends Shaping Future Development
Leading companies within the connected drug delivery devices market are concentrating on introducing advanced, longer-lasting, and more integrated digital health solutions. These innovations are designed to enhance treatment convenience, improve monitoring accuracy, and facilitate seamless connectivity with automated therapy systems. For instance, Dexcom, a US-based healthcare company, announced in November 2025 the upcoming launch of its new G7 15 Day continuous glucose monitor in the U.S. on December 1, 2025, for adults with diabetes. This device, having recently received FDA clearance, will become the longest-wearing CGM available, offering up to 15.5 days of use with an improved accuracy MARD of 8%. Upon its release, it will be accessible through DME providers and covered for Medicare users. The updated sensor is compatible with the iLet Bionic Pancreas, Omnipod 5, and will soon integrate with Tandem pumps, in addition to supporting Dexcom’s new Smart Basal insulin optimization system. With advantages like fewer sensor changes, a waterproof design, smartwatch connectivity, and simplified logging features, the G7 15 Day aims to provide greater convenience and superior long-term glucose management.
Connected Drug Delivery Devices Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, Findair Sp. z.o.o, Omron Healthcare Co. Ltd, Omnicell Inc., BD Medical
View The Full Connected Drug Delivery Devices Market Report:
Connected Drug Delivery Devices Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the connected drug delivery market in 2025. The regions covered in the connected drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
